News - POCTRN

In response to the COVID-19 pandemic, the Rapid Acceleration of Diagnostics (RADx^sm) initiative was formed to accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to clinical laboratory tests, that can directly detect SARS-CoV-2, the virus that causes COVID-19.

Learn More >>

Asset-Herausgeber

New COVID-19 Lab Pool Testing: Operational Playbook Launches on WhenToTest.org

Webinar: CORE Response: Empowering Communities to Effectively Respond to the Evolving Pandemic in the U.S. and Overseas

WhenToTest.org Develops Online Tools for Effective COVID-19 Testing

New Resources Help Schools and Businesses Reduce the Risk of an Outbreak

RADx Tech Webinar Series: A Year of RADx Tech

Global View of COVID-19: A Pan-African Perspective

RADx Pooling Task Force: Pooling Overview, Key Development Challenges for Central Laboratories and Point of Care (POC) Solutions, Regulatory Guidance for Pooling, and Implementation Examples

Webinar: COVID-19 Vaccines: How did we get here and where are we going?

Up to 100K and Mentorship Available for Innovative Neurotechnologies

Apply By June 21

RADx Tech: A New Paradigm for MedTech Development

IEEE Special Issue highlighting the insights, lessons learned, and critical components of RADx Tech

RADx Tech II: Fast-Track Program to Advance U.S. COVID-19 Testing Capabilities

Funding Opportunity

Acceleration of Sustainable K-12 School Re-openings for In-person Learning

The RADx Tech Process: Accelerating Innovation for COVID-19 Testing

Returning to In-Person Instruction for K-12 Schools: Strategic Vision and Tactical Tools

RADx Webinar: The Epidemiology of COVID-19

binx health Receives FDA CLIA Waiver for Chlamydia and Gonorrhea Test, Expanding Critical Access to Single-Visit Diagnoses

First ever 30-minute, CLIA-waived, molecular PCR Test for CT/NG now available for OBGYN, physician offices and retail settings holding certificates of waiver